Old Web
English
Sign In
Acemap
>
authorDetail
>
AB Gottlieb
AB Gottlieb
Medicine
Dermatology
Certolizumab pegol
Internal medicine
plaque psoriasis
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
312 Safety and Efficacy of Ruxolitinib Cream for the Treatment of Vitiligo: 104-Week Data From a Phase 2 Study
2021
Journal of Investigative Dermatology
John E. Harris
A.G. Pandya
Mark Lebwohl
P. Grimes
AB Gottlieb
Howard Sofen
A.Y. Moore
Kathleen Butler
Kang Sun
David Rosmarin
Show All
Source
Cite
Save
Citations (0)
303 Maintenance of Repigmentation After Discontinuation of Ruxolitinib Cream in Patients With Vitiligo
2021
Journal of Investigative Dermatology
David Rosmarin
Amit G. Pandya
P. Grimes
Mark Lebwohl
AB Gottlieb
Iltefat H. Hamzavi
Kathleen Butler
S Wei
B. Rumberger
John E. Harris
Show All
Source
Cite
Save
Citations (0)
Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis with Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial
2021
KA Papp
Mark Lebwohl
AB Gottlieb
M Sebastián
R. Langley
Y. Okubo
M. Wang
Christopher Cioffi
F. Staelens
K. Reich
Show All
Source
Cite
Save
Citations (0)
Reductions in Absolute PASI Over 144 Weeks of Treatment with Certolizumab Pegol in Patients with Plaque Psoriasis: Pooled Analysis from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)
2020
AB Gottlieb
A. Blauvelt
D. Thaci
Yves Poulin
F. Brock
C. Arendt
M Boehnlein
K. Reich
Show All
Source
Cite
Save
Citations (0)
Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT
2020
Andrew Blauvelt
AB Gottlieb
F. Fierens
F. Brock
S. Wiegratz
H. Sofen
Show All
Source
Cite
Save
Citations (0)
1